Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

I Barillot

Showing results (81-90 of 93) with videos related to

Pageof 10
Sort By:
Cancer Radiotherapie : Journal De La Societe Francaise De Radiotherapie Oncologique|August 15, 2016
[Radiotherapy of breast cancer]C Hennequin, I Barillot, D Azria, et al.
The New England Journal of Medicine|January 17, 2002
Recurrence rates after treatment of breast cancer with standard radiotherapy with or without additional radiationH Bartelink, J C Horiot, P Poortmans, et al.
American Heart Journal|May 29, 2001
Long-term prognostic value of 201Tl single-photon emission computed tomographic myocardial perfusion imaging after coronary stentingY Cottin, K Rezaizadeh, C Touzery, et al.
Cardiovascular Drugs and Therapy|April 13, 2001
Intravascular radiation and stenting: absence of efficacy on intimal proliferation in a rabbit modelD Busseuil, M Zeller, Y Cottin, et al.
International Journal of Radiation Oncology, Biology, Physics|July 4, 1998
Preoperative radiotherapy and surgery for endometrial carcinoma: prognostic significance of the sterilization of the specimenP Maingon, L Arnould, V Magnin, et al.
Revue Des Maladies Respiratoires|February 1, 2011
[A phase II study of cetuximab, pemetrexed, cisplatin, and concurrent radiotherapy in patients with locally advanced, unresectable, stage III, non squamous, non-small cell lung cancer (NSCLC)]J Tredaniel, F Mornex, I Barillot, et al.
Cancer Radiotherapie : Journal De La Societe Francaise De Radiotherapie Oncologique|July 24, 2021
[Dose optimization in 3D pulsed dose rate brachytherapy for patients with locally advanced cervical cancer: A French multicenter phase II trial]C Charra-Brunaud, J Salleron, I Menoux, et al.
Cancer Radiotherapie : Journal De La Societe Francaise De Radiotherapie Oncologique|April 7, 2019
[Stereotactic body radiation therapy for hepatocellular carcinoma: Results from a retrospective multicentre study]N Scher, G Janoray, F-G Riet, et al.
Gynecologie, Obstetrique & Fertilite|May 22, 2008
[Initial management of gynecologic cancers: reference guides of the Société Française d'Oncologie Gynécologique (SFOG) ]D Querleu, P Bonnier, P Morice, et al.
Cancer Radiotherapie : Journal De La Societe Francaise De Radiotherapie Oncologique|March 9, 2010
[Economic assessment of pulsed dose-rate (PDR) brachytherapy with optimized dose distribution for cervix carcinoma]R Remonnay, M Morelle, P Pommier, et al.
Pageof 10

Showing results (81-90 of 93) with videos related to

Sort By:
Pageof 10
Cancer Radiotherapie : Journal De La Societe Francaise De Radiotherapie Oncologique|August 15, 2016
[Radiotherapy of breast cancer]C Hennequin, I Barillot, D Azria, et al.
The New England Journal of Medicine|January 17, 2002
Recurrence rates after treatment of breast cancer with standard radiotherapy with or without additional radiationH Bartelink, J C Horiot, P Poortmans, et al.
American Heart Journal|May 29, 2001
Long-term prognostic value of 201Tl single-photon emission computed tomographic myocardial perfusion imaging after coronary stentingY Cottin, K Rezaizadeh, C Touzery, et al.
Cardiovascular Drugs and Therapy|April 13, 2001
Intravascular radiation and stenting: absence of efficacy on intimal proliferation in a rabbit modelD Busseuil, M Zeller, Y Cottin, et al.
International Journal of Radiation Oncology, Biology, Physics|July 4, 1998
Preoperative radiotherapy and surgery for endometrial carcinoma: prognostic significance of the sterilization of the specimenP Maingon, L Arnould, V Magnin, et al.
Revue Des Maladies Respiratoires|February 1, 2011
[A phase II study of cetuximab, pemetrexed, cisplatin, and concurrent radiotherapy in patients with locally advanced, unresectable, stage III, non squamous, non-small cell lung cancer (NSCLC)]J Tredaniel, F Mornex, I Barillot, et al.
Cancer Radiotherapie : Journal De La Societe Francaise De Radiotherapie Oncologique|July 24, 2021
[Dose optimization in 3D pulsed dose rate brachytherapy for patients with locally advanced cervical cancer: A French multicenter phase II trial]C Charra-Brunaud, J Salleron, I Menoux, et al.
Cancer Radiotherapie : Journal De La Societe Francaise De Radiotherapie Oncologique|April 7, 2019
[Stereotactic body radiation therapy for hepatocellular carcinoma: Results from a retrospective multicentre study]N Scher, G Janoray, F-G Riet, et al.
Gynecologie, Obstetrique & Fertilite|May 22, 2008
[Initial management of gynecologic cancers: reference guides of the Société Française d'Oncologie Gynécologique (SFOG) ]D Querleu, P Bonnier, P Morice, et al.
Cancer Radiotherapie : Journal De La Societe Francaise De Radiotherapie Oncologique|March 9, 2010
[Economic assessment of pulsed dose-rate (PDR) brachytherapy with optimized dose distribution for cervix carcinoma]R Remonnay, M Morelle, P Pommier, et al.
Pageof 10